Abstract

Background: Nuclear protein-1 (NUPR1, also known as p8/Com-1) is a transcription factor involved in the regulation of cellular stress responses, including serum starvation and drug stimulation. Methods: We investigated the mechanism of NUPR1 nuclear translocation involving karyopherin β1 (KPNB1), using a single-molecule binding assay and confocal microscopy. The cellular effects associated with NUPR1–KPNB1 inhibition were investigated by gene expression profiling and cell cycle analysis. Results: The single-molecule binding assay revealed that KPNB1 bound to NUPR1 with a binding affinity of 0.75 nM and that this binding was blocked by the aminothiazole ATZ-502. Following doxorubicin-only treatment, NUPR1 was translocated to the nucleus in more than 90% and NUPR1 translocation was blocked by the ATZ-502 combination treatment in MDA-MB-231 with no change in NUPR1 expression, providing strong evidence that NUPR1 nuclear translocation was directly inhibited by the ATZ-502 treatment. Inhibition of KPNB1 and NUPR1 binding was associated with a synergistic anticancer effect (up to 19.6-fold) in various cancer cell lines. NUPR1-related genes were also downregulated following the doxorubicin–ATZ-502 combination treatment. Conclusion: Our current findings clearly demonstrate that NUPR1 translocation into the nucleus requires karyopherin β1 binding. Inhibition of the KPNB1 and NUPR1 interaction may constitute a new cancer therapeutic approach that can increase the drug efficacy while reducing the side effects.

Highlights

  • The transcription factor nuclear protein-1 (NUPR1, aka p8/Com-1) is a member of the high-mobility group of transcriptional regulators [1], and it plays an important role in several different biological processes, including transcription, cell cycle, autophagy, and cell death [2,3,4]

  • MDA-MB 231 cells were treated with doxorubicin for 24, 48, and 72 h to investigate the effects of doxorubicin cytotoxicity

  • We established the importance of the protein–protein binding interaction between NUPR1 and karyopherin β1 in the protein nuclear translocation mechanism, and we demonstrated that ATZ-502 inhibited this interaction

Read more

Summary

Introduction

The transcription factor nuclear protein-1 (NUPR1, aka p8/Com-1) is a member of the high-mobility group of transcriptional regulators [1], and it plays an important role in several different biological processes, including transcription, cell cycle, autophagy, and cell death [2,3,4]. NUPR1 is a component of the cellular stress response, playing a role in serum starvation, oxidative stress, and drug stimulation, and it is overexpressed in various cancers [5,6,7]. NUPR1 is involved in the translocation of p27 from the nucleus to cytoplasm in pancreatic cells. Nuclear protein-1 (NUPR1, known as p8/Com-1) is a transcription factor involved in the regulation of cellular stress responses, including serum starvation and drug stimulation. Methods: We investigated the mechanism of NUPR1 nuclear translocation involving karyopherin β1 (KPNB1), using a single-molecule binding assay and confocal microscopy. Inhibition of KPNB1 and NUPR1 binding was associated with a synergistic anticancer effect (up to 19.6-fold) in various cancer cell lines. Inhibition of the KPNB1 and NUPR1 interaction may constitute a new cancer therapeutic approach that can increase the drug efficacy while reducing the side effects

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.